{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T11:47:10Z","timestamp":1768736830359,"version":"3.49.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.lfs.2015.12.016","type":"journal-article","created":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T18:37:23Z","timestamp":1449945443000},"page":"74-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Chemopreventive agents targeting tumor microenvironment"],"prefix":"10.1016","volume":"145","author":[{"given":"Sharada H.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senthilkumar","family":"Thulasingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeetha","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2015.12.016_bb0005","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/bies.201100025","article-title":"The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory","volume":"33","author":"Soto","year":"2011","journal-title":"BioEssays"},{"key":"10.1016\/j.lfs.2015.12.016_bb0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.semcancer.2007.06.009","article-title":"Tumor immunoediting and immunosculpting pathways to cancer progression","volume":"17","author":"Reiman","year":"2007","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canlet.2013.01.042","article-title":"Microenvironment and tumor cell plasticity: an easy way out","volume":"341","author":"Taddei","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2015.12.016_bb0020","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.semcancer.2013.08.007","article-title":"Tumor and its microenvironment: a synergistic interplay","volume":"23","author":"Catalano","year":"2013","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cas.12314","article-title":"Clinical significance of macrophage heterogeneity in human malignant tumors","volume":"105","author":"Komohara","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lfs.2015.12.016_bb0030","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.4049\/jimmunol.173.3.1731","article-title":"A synthetic peptide homologous to functional domain of human IL-10 down-regulates expression of MHC class I and transporter associated with antigen processing 1\/2 in human melanoma cells","volume":"173","author":"Kurte","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.semcancer.2005.07.006","article-title":"Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators","volume":"16","author":"Ben-Baruch","year":"2006","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0040","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.molimm.2008.08.266","article-title":"Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression","volume":"46","author":"Bak","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0045","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1600-065X.2008.00602.x","article-title":"Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells","volume":"222","author":"Marigo","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.lfs.2015.12.016_bb0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.coi.2010.01.009","article-title":"Macrophages, innate immunity and cancer: balance, tolerance, and diversity","volume":"22","author":"Mantovani","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0055","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.lungcan.2011.04.009","article-title":"Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression","volume":"74","author":"Wang","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lfs.2015.12.016_bb0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1158\/1940-6207.CAPR-08-0095","article-title":"Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-\u03baB and signal transducers and activators of transcription 3","volume":"2","author":"Tyagi","year":"2009","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.lfs.2015.12.016_bb0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1479-5876-9-177","article-title":"Tumour macrophages as potential targets of bisphosphonates","volume":"9","author":"Rogers","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.lfs.2015.12.016_bb0070","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ccr.2013.01.008","article-title":"Role of macrophage targeting in the antitumor activity of trabectedin","volume":"23","author":"Germano","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2015.12.016_bb0075","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1582-4934.2009.00926.x","article-title":"Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway","volume":"14","author":"Coscia","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.lfs.2015.12.016_bb0080","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.molonc.2014.12.010","article-title":"Modulation of the tumor microenvironment and inhibition of EGF\/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer","volume":"9","author":"Elbaz","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0085","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrc1477","article-title":"Friends or foes \u2014 bipolar effects of the tumour stroma in cancer","volume":"4","author":"Mueller","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2015.12.016_bb0090","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2353\/ajpath.2009.081030","article-title":"Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer","volume":"175","author":"Paulsson","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0095","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.biocel.2006.11.005","article-title":"Fibroblasts and myofibroblasts: their source, function and role in disease","volume":"39","author":"McAnulty","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0100","first-page":"482","article-title":"Cancer associated fibroblasts: the dark side of the coin","volume":"1","author":"Cirri","year":"2011","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.lfs.2015.12.016_bb0105","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","article-title":"Matrix crosslinking forces tumor progression by enhancing integrin signaling","volume":"139","author":"Levental","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2015.12.016_bb0110","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.febslet.2009.12.039","article-title":"The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling","volume":"584","author":"Blasi","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2015.12.016_bb0115","article-title":"Therapeutic targeting of tumor-stroma interactions","volume":"609-21","author":"Hiscox","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.lfs.2015.12.016_bb0120","article-title":"Silibinin prevents prostate cancer cell-mediated differentiation of na\u00efve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF \u03b22","author":"Ting","year":"2014","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.lfs.2015.12.016_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090907","article-title":"Caffeine mediates sustained inactivation of breast cancer-associated myofibroblasts via up-regulation of tumor suppressor genes","volume":"9","author":"Al-Ansari","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2015.12.016_bb0130","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2015.12.016_bb0135","doi-asserted-by":"crossref","first-page":"66","DOI":"10.7150\/jca.5112","article-title":"The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas","volume":"4","author":"Koontongkaew","year":"2013","journal-title":"J. Cancer."},{"key":"10.1016\/j.lfs.2015.12.016_bb0140","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0145","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/ijc.24497","article-title":"Pretreatment frequency of circulating IL-17+CD4+ T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients","volume":"125","author":"Derhovanessian","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2015.12.016_bb0150","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.4049\/jimmunol.0902813","article-title":"Tumor microenvironments direct the recruitment and expansion of human Th17 cells","volume":"184","author":"Su","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0155","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.4049\/jimmunol.0901017","article-title":"Protumor vs antitumor functions of IL-17","volume":"183","author":"Murugaiyan","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0160","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nri2742","article-title":"T(H)17 cells in tumour immunity and immunotherapy","volume":"10","author":"Zou","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0165","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajpath.2012.08.041","article-title":"The role and regulation of human Th17 cells in tumor immunity","volume":"182","author":"Ye","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0170","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25)","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0175","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/cmi.2010.11","article-title":"Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts","volume":"7","author":"Bhattacharyya","year":"2010","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0180","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1158\/1940-6207.CAPR-11-0308","article-title":"Immunomodulation of curcumin on adoptive therapy with T cell functional imaging in mice","volume":"5","author":"Chang","year":"2012","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.lfs.2015.12.016_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-immunol-100311-102839","article-title":"Decisions about dendritic cells: past, present, and future","volume":"30","author":"Steinman","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0190","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.4049\/jimmunol.165.11.6037","article-title":"BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood","volume":"165","author":"Dzionek","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0195","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/08820130600803429","article-title":"Dendritic cells and tumor microenvironment: a dangerous liaison","volume":"35","author":"Fricke","year":"2006","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.lfs.2015.12.016_bb0200","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/425476","article-title":"Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination","volume":"2012","author":"Benencia","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0205","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1084\/jem.20061120","article-title":"Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development","volume":"204","author":"Aspord","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2015.12.016_bb0210","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1084\/jem.20020732","article-title":"Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody","volume":"196","author":"Vicari","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2015.12.016_bb0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0065-230X(04)92002-7","article-title":"Tumor-host immune interactions and dendritic cell dysfunction","volume":"92","author":"Yang","year":"2004","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.lfs.2015.12.016_bb0220","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4161\/cbt.9.12.12347","article-title":"Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics","volume":"9","author":"Lin","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.lfs.2015.12.016_bb0225","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1440-1711.2005.01371.x","article-title":"Dendritic cell dysfunction in cancer: a mechanism for immunosuppression","volume":"83","author":"Pinzon-Charry","year":"2005","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1074-7613(00)80014-X","article-title":"Other functions, other genes: alternative activation of antigen-presenting cells","volume":"10","author":"Goerdt","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2015.12.016_bb0235","doi-asserted-by":"crossref","first-page":"495","DOI":"10.5306\/wjco.v5.i3.495","article-title":"Pattern response of dendritic cells in the tumor microenvironment and breast cancer","volume":"5","author":"Da Cunha","year":"2014","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0240","doi-asserted-by":"crossref","first-page":"9299","DOI":"10.1158\/0008-5472.CAN-06-1690","article-title":"All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients","volume":"66","author":"Mirza","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2015.12.016_bb0245","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1158\/1940-6207.CAPR-12-0320","article-title":"Bioactive grape proanthocyanidins enhance immune reactivity in UV\u2013irradiated skin through functional activation of dendritic cells in mice","volume":"6","author":"Vaid","year":"2013","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.lfs.2015.12.016_bb0250","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1517\/14728222.9.4.831","article-title":"Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors","volume":"9","author":"Muller","year":"2005","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.lfs.2015.12.016_bb0255","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1182\/blood-2007-10-116111","article-title":"Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells","volume":"111","author":"Lob","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2015.12.016_bb0260","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1182\/blood-2008-12-195354","article-title":"Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes","volume":"113","author":"Sharma","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2015.12.016_bb0265","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1038\/sj.onc.1210939","article-title":"A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase.","volume":"27","author":"Banerjee","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2015.12.016_bb0270","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbrc.2012.10.009","article-title":"Natural inhibitors of indoleamine 3,5-dioxygenase induced by interferon-gamma in human neural stem cells","volume":"429","author":"Chen","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2015.12.016_bb0275","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.bbrc.2007.01.076","article-title":"(\u2212)-Epigallocatechin gallate suppresses indoleamine 2,3-dioxygenase expression in murine dendritic cells: evidences for the COX-2 and STAT1 as potential targets","volume":"354","author":"Jeong","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2015.12.016_bb0280","article-title":"Broad targeting of angiogenesis for cancer prevention and therapy","volume":"1\u201320","author":"Wang","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0285","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/01.RES.77.3.638","article-title":"Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5\u2032 enhancer.","volume":"77","author":"Liu","year":"1995","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2015.12.016_bb0290","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jnci\/93.4.309","article-title":"Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis","volume":"93","author":"Bos","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.lfs.2015.12.016_bb0295","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(03)00194-6","article-title":"The hypoxic response of tumors is dependent on their microenvironment","volume":"4","author":"Blouw","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2015.12.016_bb0300","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.bbrc.2010.03.089","article-title":"Isolated tumor endothelial cells maintain specific character during long-term culture","volume":"394","author":"Matsuda","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2015.12.016_bb0305","first-page":"3799","article-title":"Tumor endothelial cells are targets for selective therapies: in vitro and in vivo models to evaluate antiangiogenic strategies","volume":"25","author":"Dutour","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lfs.2015.12.016_bb0310","first-page":"237","article-title":"Anti-angiogenic therapy: rationale, challenges and clinical studies","author":"Longo","year":"2003","journal-title":"Angiogenesis"},{"key":"10.1016\/j.lfs.2015.12.016_bb0315","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2015.12.016_bb0320","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1007\/s00018-004-4070-7","article-title":"Angiogenesis and signal transduction in endothelial cells","volume":"61","author":"Mu\u00f1oz-Ch\u00e1puli","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2015.12.016_bb0325","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10555-007-9108-5","article-title":"Inflammation, inflammatory cells and angiogenesis: decisions and indecisions","volume":"27","author":"Noonan","year":"2008","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.lfs.2015.12.016_bb0330","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/ijc.23647","article-title":"Sulforaphane inhibited expression of hypoxia-inducible factor-1alpha in human tongue squamous cancer cells and prostate cancer cells","volume":"123","author":"Yao","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2015.12.016_bb0335","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.canlet.2008.01.043","article-title":"Celastrol inhibits the growth of human glioma xenografts in nude mice through suppressing VEGFR expression","volume":"264","author":"Huang","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2015.12.016_bb0340","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00280-005-0014-7","article-title":"Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes","volume":"57","author":"Straight","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0345","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.bbrc.2005.03.109","article-title":"Antiangiogenic activity of 4-O-methylgallic acid from Canavalia gladiata, a dietary legume","volume":"330","author":"Jeon","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2015.12.016_bb0350","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/carcin\/bgi024","article-title":"Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound","volume":"26","author":"Labrecque","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lfs.2015.12.016_bb0355","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/carcin\/bgn070","article-title":"Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand\/receptor (PDGF\/PDGFR) signaling","volume":"29","author":"Lamy","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lfs.2015.12.016_bb0360","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3945\/jn.108.100966","article-title":"Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57\/BL mice","volume":"139","author":"Ejaz","year":"2009","journal-title":"J. Nutr."},{"key":"10.1016\/j.lfs.2015.12.016_bb0365","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1096\/fj.01-0028fje","article-title":"Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes","volume":"15","author":"Br\u00e5kenhielm","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2015.12.016_bb0370","first-page":"299","article-title":"Flavonoids targeting of I\u03baB phosphorylation abrogates carcinogen-induced MMP-9 and COX-2 expression in human brain endothelial cells","volume":"5","author":"Tahanian","year":"2011","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.lfs.2015.12.016_bb0375","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0955-2863(02)00204-8","article-title":"Antiangiogenic mechanisms of diet-derived polyphenols","volume":"13","author":"Cao","year":"2002","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.lfs.2015.12.016_bb0380","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/879623","article-title":"Tumor angiogenesis as a target for dietary cancer prevention","volume":"2012","author":"Li","year":"2012","journal-title":"J. Oncol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0385","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.yexcr.2005.10.019","article-title":"Pericytes and vascular stability","volume":"312","author":"Von Tell","year":"2006","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.lfs.2015.12.016_bb0390","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/ATVBAHA.107.161521","article-title":"Endothelial\u2013mural cell signaling in vascular development and angiogenesis","volume":"29","author":"Gaengel","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0395","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/jcb.23447","article-title":"Cross-talk between endothelial and breast cancer cells regulates reciprocal expression of angiogenic factors in vitro","volume":"113","author":"Buchanan","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.lfs.2015.12.016_bb0400","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.RES.0000182903.16652.d7","article-title":"Endothelial\/pericyte interactions","volume":"97","author":"Armulik","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2015.12.016_bb0405","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1016\/j.ajpath.2011.02.008","article-title":"Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation","volume":"178","author":"Fuxe","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0410","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1242\/jcs.01653","article-title":"The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism","volume":"118","author":"Scharpfenecker","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.lfs.2015.12.016_bb0415","first-page":"909","article-title":"Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche","volume":"24","author":"D\u00edaz-Flores","year":"2009","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0420","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.RES.0000102937.50486.1B","article-title":"Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1","volume":"93","author":"Kelly","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2015.12.016_bb0425","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10456-009-9147-3","article-title":"The role of the angiopoietins in vascular morphogenesis","volume":"12","author":"Thomas","year":"2009","journal-title":"Angiogenesis"},{"key":"10.1016\/j.lfs.2015.12.016_bb0430","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.gde.2004.12.005","article-title":"Cellular abnormalities of blood vessels as targets in cancer","volume":"15","author":"Baluk","year":"2005","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.lfs.2015.12.016_bb0435","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2337\/diabetes.53.4.1104","article-title":"Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy","volume":"53","author":"Hammes","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2015.12.016_bb0440","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1096\/fj.03-0271fje","article-title":"Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms","volume":"18","author":"Erber","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2015.12.016_bb0445","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1172\/JCI200317929","article-title":"Benefits of targeting both pericycles and endothelial cells in the tumour vasculature with kinase inhibitors","volume":"111","author":"Bergers","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2015.12.016_bb0450","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/ijc.22999","article-title":"Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling","volume":"121","author":"Hasumi","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2015.12.016_bb0455","doi-asserted-by":"crossref","first-page":"10185","DOI":"10.1073\/pnas.0803194105","article-title":"Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis","volume":"105","author":"Kuhnert","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2015.12.016_bb0460","doi-asserted-by":"crossref","first-page":"122","DOI":"10.18632\/oncotarget.234","article-title":"Recent advances in anti-angiogenic therapy of Cancer abstract: VEGF matrix degradation MMPs sunitinib sorafenib rapamycin bFGF TGF- \u03b1 bevacizumab cetuximab panitumumab erlotinib (TKI)","volume":"2","author":"Samant","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2015.12.016_bb0465","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1586\/erp.11.33","article-title":"Cost-effectiveness of sunitinib in metastatic renal cell carcinoma","author":"Purmonen","year":"2011","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"10.1016\/j.lfs.2015.12.016_bb0470","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/1471-2407-12-192","article-title":"Methylseleninic acid restricts tumor growth in nude mice model of metastatic breast cancer probably via inhibiting angiopoietin-2","volume":"12","author":"Wu","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2015.12.016_bb0475","article-title":"Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy","volume":"1-16","author":"Ammendola","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.lfs.2015.12.016_bb0480","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/978-1-4419-9533-9_14","article-title":"Mast cells, angiogenesis and cancer","volume":"716","author":"Ribatti","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0485","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood-2008-03-147033","article-title":"SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment","volume":"112","author":"Huang","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2015.12.016_bb0490","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0008922","article-title":"Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model","volume":"5","author":"Yang","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.lfs.2015.12.016_bb0495","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pupt.2004.09.032","article-title":"Inhibitors of mast cell tryptase beta as therapeutics for the treatment of asthma and inflammatory disorders","volume":"18","author":"Cairns","year":"2005","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2015.12.016_bb0500","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.2174\/138161209788453284","article-title":"Mast cells as target in cancer therapy","volume":"15","author":"Groot Kormelink","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.lfs.2015.12.016_bb0505","article-title":"Silibinin modulates caudal-type homeobox transcription factor (CDX2), an intestine specific tumor suppressor to abrogate colon cancer in experimental rats","author":"Sangeetha","year":"2014","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0510","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.4049\/jimmunol.147.7.2253","article-title":"Tumor necrosis factor-alpha dependent cytotoxicity of human skin mast cells is enhanced by anti-IgE antibodies","volume":"147","author":"Benyon","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0515","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2567.2000.00982.x","article-title":"Redundancy or cell-type-specific regulation? Tumour necrosis factor in alveolar macrophages and mast cells","volume":"99","author":"D\u00e9ry","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.lfs.2015.12.016_bb0520","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3748\/wjg.v11.i8.1210","article-title":"Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer","volume":"11","author":"Tan","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2015.12.016_bb0525","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10549-007-9546-3","article-title":"Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases","volume":"107","author":"Rajput","year":"2008","journal-title":"Breast Cancer Res. Treat."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320515301077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320515301077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T04:14:21Z","timestamp":1692159261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320515301077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":105,"alternative-id":["S0024320515301077"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2015.12.016","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemopreventive agents targeting tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2015.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}